Biolase Inc COM PAR $.001 NEW reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Biolase Inc COM PAR $.001 NEW using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $-0.04 | $-0.06 | 33.3 % |
Q2 | 2024-08-08 | $-0.08 | $-0.07 | -14.3 % |
Q1 | 2024-05-13 | $-0.36 | $-0.17 | -111.8 % |
Q4 | 2024-03-21 | $-1.76 | $-2.55 | 31.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $10.85M | $11.40M | -4.82 % |
Q2 | 2024-08-08 | $11.56M | $13.49M | -14.3 % |
Q1 | 2024-05-13 | $10.13M | $10.00M | 1.31 % |
Q4 | 2024-03-21 | $13.49M | $13.55M | -0.44 % |
Biolase Inc COM PAR $.001 NEW (BIOL) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.04, which beat the estimate of $-0.06.
The Actual Revenue was $10.8M, which missed the estimate of $11.4M.
Browse earnings estimates, EPS, and revenue on all stocks.